|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV033960666 |
| 003 |
DE-627 |
| 005 |
20230624001909.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
180603s2014 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.earlhumdev.2014.07.012
|2 doi
|
| 028 |
5 |
2 |
|a GBVA2014012000026.pica
|
| 035 |
|
|
|a (DE-627)ELV033960666
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(14)00180-7
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Oh, Ki Won
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Establishing a reference range for triiodothyronine levels in preterm infants
|
| 264 |
|
1 |
|c 2014
|
| 300 |
|
|
|a 4
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a Thyroid dysfunction affects clinical complications in preterm infants and older children. However, thyroid hormone replacement in preterm infants has no proven benefits, possibly owing to the lack of an appropriate reference range for thyroid hormone levels. We aimed to establish a reference range for triiodothyronine (T3) levels at 1-month postnatal age (PNA) in preterm infants.
|
| 700 |
1 |
|
|a Koo, Mi Sung
|4 oth
|
| 700 |
1 |
|
|a Park, Hye Won
|4 oth
|
| 700 |
1 |
|
|a Chung, Mi Lim
|4 oth
|
| 700 |
1 |
|
|a Kim, Min-ho
|4 oth
|
| 700 |
1 |
|
|a Lim, Gina
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:90
|g year:2014
|g number:10
|g pages:621-624
|g extent:4
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2014.07.012
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 90
|j 2014
|e 10
|h 621-624
|g 4
|
| 953 |
|
|
|2 045F
|a 610
|